Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,095
Total Claims
$962K
Drug Cost
642
Beneficiaries
$1,499
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-53%
Opioid rate vs peers
1.2% vs 2.6% avg
+21%
Cost per patient vs peers
$1,499 vs $1,237 avg
+40%
Brand preference vs peers
12.8% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.2%
Opioid Rate
170
Opioid Claims
$3,624
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,801 claims · $622K
Generic: 12,232 claims · $338K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 542 | $204K |
| Pimavanserin Tartrate | 19 | $40K |
| Lipase/Protease/Amylase | 29 | $35K |
| Rivaroxaban | 79 | $32K |
| Sitagliptin Phosphate | 34 | $31K |
| Sevelamer Carbonate | 41 | $23K |
| Dolutegravir Sodium | 11 | $19K |
| Enoxaparin Sodium | 192 | $16K |
| Atorvastatin Calcium | 1,057 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 48 | $14K |
| Linaclotide | 25 | $14K |
| Potassium Chloride | 353 | $13K |
| Mirabegron | 27 | $12K |
| Umeclidinium Brm/Vilanterol Tr | 31 | $12K |
| Empagliflozin | 23 | $11K |
Prescribing Profile
Patient Profile
81
Avg Age
56%
Female
2.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About